IR & PR Clients

See why more than 250 companies chose WWFinancial to increase awareness, coverage and relevance.

Read Our Clients' Stories
CEO, Usio, Inc.

Louis Hoch

usio.com

“Having worked with WWFinancial in the past, I had no hesitation in again engaging the firm when Usio, Inc. needed to institute an investor relations program. As I had expected, …

READ FULL STORY
CEO, Sonoma Pharmaceuticals

Jim Schutz

sonomapharma.com

“For small and micro-cap companies like Sonoma Pharmaceuticals, it doesn’t make any sense to have an in-house investor relations professional when there is a firm like WWFinancial that can provide …

READ FULL STORY
Former CEO, IsoRay

Dwight Babcock

isoray.com

“We had a terrific, productive relationship with WWFinancial, at a pivotal point in IsoRay’s development. The WWFinancial was highly engaged with us, personalizing their efforts to seamlessly match our philosophies …

READ FULL STORY
usio.com
NASDAQ
PYDS
INDUSTRY
Financial
TYPE
B2C, B2B

Usio, Inc.

Usio, Inc. is an integrated payment solutions provider to merchants and billers. The organization provides an extensive set of products to deliver world-class payment acceptance. Usio has solutions for merchants, …

WWFinancial Provided

Implemented a comprehensive Financial PR program at the same time as the company uplisting to the NASDAQ market.

Result

After the first half of our program launch, the 20d average volume gradually increased from 4,000 shares to over 300,000 shares.

Read More
gromsocial.com
OTC
GRMM
INDUSTRY
Entertainment
TYPE
B2C

Grom Social, Inc.

Grom Social Enterprises, Inc., through its subsidiaries, operates social media network designed for children in the United States. It is also involved in the animation business; and provision of WebFiltering …

WWFinancial Provided

Financial PR and investor engagement.

Result

Increased retail brokerage sponsorship and investor awareness.

Read More
actiniumpharma.com
NYSE
ATNM
INDUSTRY
Biotech
TYPE
B2C

Actinium Pharmaceuticals, Inc.

Actinium is developing two radioimmunotherapy (RIT) drugs based on its APIT drug delivery platform. Iomab-B is being developed for bone marrow conditioning for hematopoietic stem cell transplantation (HSCT) in relapsed …

WWFinancial Provided

PROVIDED

Result

Text result

Read More
ibioinc.com
NYSE
IBIO
INDUSTRY
Pharmaceutical
TYPE
B2C

iBio, Inc.

iBio, Inc. develops pharmaceutical product applications using its iBio Technology platform; a platform that has proven to be more efficient and cost-effective than traditional systems. The iBioLaunch platform is a …

WWFinancial Provided

We applied strategic marketing techniques toward enhancing interest in the institutional and analysts community.

Result

Increased the 20d average volume from 50K shares a day to over 120K.

Read More
sonomapharma.com
NASDAQ
SNOA
INDUSTRY
Pharmaceutical
TYPE
B2C

Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals is a specialty pharmaceutical company that develops and markets unique and effective solutions for the treatment of dermatological conditions and advanced tissue care. The company’s products, which are …

WWFinancial Provided

Engaged proactive marketing program to generate retail brokerage sponsorship.

Result

Institutional holdings increased 20% within first 6 months of program.

Read More

We help you market your investment story with maximum impact and deliver your corporate message effectively

Contact Us
or call
+1 954 360 9998